BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11549251)

  • 1. Expression of TGF-beta signaling genes in the normal, premalignant, and malignant human trophoblast: loss of smad3 in choriocarcinoma cells.
    Xu G; Chakraborty C; Lala PK
    Biochem Biophys Res Commun; 2001 Sep; 287(1):47-55. PubMed ID: 11549251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of TGF-beta regulation of plasminogen activator inhibitor-1 in Smad3-restituted human choriocarcinoma cells.
    Xu G; Chakraborty C; Lala PK
    Biochem Biophys Res Commun; 2002 Jun; 294(5):1079-86. PubMed ID: 12074587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta.
    Graham CH; Connelly I; MacDougall JR; Kerbel RS; Stetler-Stevenson WG; Lala PK
    Exp Cell Res; 1994 Sep; 214(1):93-9. PubMed ID: 8082752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstitution of Smad3 restores TGF-beta response of tissue inhibitor of metalloprotease-1 upregulation in human choriocarcinoma cells.
    Xu G; Chakraborty C; Lala PK
    Biochem Biophys Res Commun; 2003 Jan; 300(2):383-90. PubMed ID: 12504095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer.
    Kleeff J; Ishiwata T; Maruyama H; Friess H; Truong P; Büchler MW; Falb D; Korc M
    Oncogene; 1999 Sep; 18(39):5363-72. PubMed ID: 10498890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
    Fink SP; Mikkola D; Willson JK; Markowitz S
    Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
    Alvarez J; Serra R
    Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
    Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
    Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of TGF-beta type II receptor, Smad2, Smad3, Smad4, Smad6 and Smad7 genes in colorectal cancer.
    Fukushima T; Mashiko M; Takita K; Otake T; Endo Y; Sekikawa K; Takenoshita S
    J Exp Clin Cancer Res; 2003 Jun; 22(2):315-20. PubMed ID: 12866583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4.
    Kretschmer A; Moepert K; Dames S; Sternberger M; Kaufmann J; Klippel A
    Oncogene; 2003 Oct; 22(43):6748-63. PubMed ID: 14555988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smads in human trophoblast cells: expression, regulation and role in TGF-beta-induced transcriptional activity.
    Wu D; Luo S; Wang Y; Zhuang L; Chen Y; Peng C
    Mol Cell Endocrinol; 2001 Apr; 175(1-2):111-21. PubMed ID: 11325521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling "cross-talk" between TGF-beta1 and ECM signals in chondrocytic cells.
    Schneiderbauer MM; Dutton CM; Scully SP
    Cell Signal; 2004 Oct; 16(10):1133-40. PubMed ID: 15240008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased Smad4 expression in the transforming growth factor-beta signaling pathway during progression of esophageal squamous cell carcinoma.
    Fukuchi M; Masuda N; Miyazaki T; Nakajima M; Osawa H; Kato H; Kuwano H
    Cancer; 2002 Aug; 95(4):737-43. PubMed ID: 12209716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
    Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burn injury induces an inhibitory signal in the lung Smad pathway.
    Pham TN; Cho K; Adamson LK; Hakimbashi M; Yang L; Tredget EE; Greenhalgh DG
    Cytokine; 2004 Jul 21-Aug 7; 27(2-3):66-73. PubMed ID: 15242695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad4-independent regulation of p21/WAF1 by transforming growth factor-beta.
    Ijichi H; Otsuka M; Tateishi K; Ikenoue T; Kawakami T; Kanai F; Arakawa Y; Seki N; Shimizu K; Miyazono K; Kawabe T; Omata M
    Oncogene; 2004 Feb; 23(5):1043-51. PubMed ID: 14762439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
    Tian F; Byfield SD; Parks WT; Stuelten CH; Nemani D; Zhang YE; Roberts AB
    Cancer Res; 2004 Jul; 64(13):4523-30. PubMed ID: 15231662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential gene expression pattern between normal human trophoblast and choriocarcinoma cell lines: downregulation of heat shock protein-27 in choriocarcinoma in vitro and in vivo.
    Vegh GL; Fulop V; Liu Y; Ng SW; Tuncer ZS; Genest DR; Paldi-Haris P; Foldi J; Mok SC; Berkowitz RS
    Gynecol Oncol; 1999 Dec; 75(3):391-6. PubMed ID: 10600295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.